287 related articles for article (PubMed ID: 12198032)
1. The pharmacokinetics and tolerability of an intravenous infusion of the new hydroxyethyl starch 130/0.4 (6%, 500 mL) in mild-to-severe renal impairment.
Jungheinrich C; Scharpf R; Wargenau M; Bepperling F; Baron JF
Anesth Analg; 2002 Sep; 95(3):544-51, table of contents. PubMed ID: 12198032
[TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetics and safety of 6 % hydroxyethyl starch 130/0.4 in healthy male volunteers of Japanese ethnicity after single infusion of 500 ml solution.
Yamakage M; Bepperling F; Wargenau M; Miyao H
J Anesth; 2012 Dec; 26(6):851-7. PubMed ID: 22729229
[TBL] [Abstract][Full Text] [Related]
3. Hydroxyethyl starch (HES) [130/0.4], a new HES specification: pharmacokinetics and safety after multiple infusions of 10% solution in healthy volunteers.
Waitzinger J; Bepperling F; Pabst G; Opitz J
Drugs R D; 2003; 4(3):149-57. PubMed ID: 12757400
[TBL] [Abstract][Full Text] [Related]
4. Bioequivalence comparison between hydroxyethyl starch 130/0.42/6 : 1 and hydroxyethyl starch 130/0.4/9 : 1.
Lehmann G; Marx G; Förster H
Drugs R D; 2007; 8(4):229-40. PubMed ID: 17596109
[TBL] [Abstract][Full Text] [Related]
5. The pharmacokinetics of acetyl starch as a plasma volume expander in patients undergoing elective surgery.
Behne M; Thomas H; Bremerich DH; Lischke V; Asskali F; Förster H
Anesth Analg; 1998 Apr; 86(4):856-60. PubMed ID: 9539615
[TBL] [Abstract][Full Text] [Related]
6. Voluven, a lower substituted novel hydroxyethyl starch (HES 130/0.4), causes fewer effects on coagulation in major orthopedic surgery than HES 200/0.5.
Langeron O; Doelberg M; Ang ET; Bonnet F; Capdevila X; Coriat P
Anesth Analg; 2001 Apr; 92(4):855-62. PubMed ID: 11273914
[TBL] [Abstract][Full Text] [Related]
7. [Volume replacement with hydroxyethyl starch: is there an influence on kidney function?].
Suttner S; Boldt J
Anasthesiol Intensivmed Notfallmed Schmerzther; 2004 Feb; 39(2):71-7. PubMed ID: 14767795
[TBL] [Abstract][Full Text] [Related]
8. [The accumulation of different substituted hydroxyethyl starches (HES) following repeated infusions in healthy volunteers].
Asskali F; Förster H
Anasthesiol Intensivmed Notfallmed Schmerzther; 1999 Sep; 34(9):537-41. PubMed ID: 10542895
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetics of hydroxyethyl starch.
Jungheinrich C; Neff TA
Clin Pharmacokinet; 2005; 44(7):681-99. PubMed ID: 15966753
[TBL] [Abstract][Full Text] [Related]
10. HES 130/0.42 shows less alteration of pharmacokinetics than HES 200/0.5 when dosed repeatedly.
Lehmann GB; Asskali F; Boll M; Burmeister MA; Marx G; Hilgers R; Förster H
Br J Anaesth; 2007 May; 98(5):635-44. PubMed ID: 17456491
[TBL] [Abstract][Full Text] [Related]
11. Pharmacodynamics and tolerability of acetyl starch as a new plasma volume expander in patients undergoing elective surgery.
Bremerich DH; Lischke V; Asskali F; Förster H; Behne M
Int J Clin Pharmacol Ther; 2000 Aug; 38(8):408-14. PubMed ID: 10984015
[TBL] [Abstract][Full Text] [Related]
12. Hydroxyethyl starch in balanced electrolyte solution (Hextend)--pharmacokinetic and pharmacodynamic profiles in healthy volunteers.
Wilkes NJ; Woolf RL; Powanda MC; Gan TJ; Machin SJ; Webb A; Mutch M; Bennett-Guerrero E; Mythen M
Anesth Analg; 2002 Mar; 94(3):538-44; table of contents. PubMed ID: 11867371
[TBL] [Abstract][Full Text] [Related]
13. Effect of molecular weight and substitution on tissue uptake of hydroxyethyl starch: a meta-analysis of clinical studies.
Bellmann R; Feistritzer C; Wiedermann CJ
Clin Pharmacokinet; 2012 Apr; 51(4):225-36. PubMed ID: 22420578
[TBL] [Abstract][Full Text] [Related]
14. Repetitive large-dose infusion of the novel hydroxyethyl starch 130/0.4 in patients with severe head injury.
Neff TA; Doelberg M; Jungheinrich C; Sauerland A; Spahn DR; Stocker R
Anesth Analg; 2003 May; 96(5):1453-1459. PubMed ID: 12707149
[TBL] [Abstract][Full Text] [Related]
15. Tissue deposits of hydroxyethyl starch (HES): dose-dependent and time-related.
Sirtl C; Laubenthal H; Zumtobel V; Kraft D; Jurecka W
Br J Anaesth; 1999 Apr; 82(4):510-5. PubMed ID: 10472213
[TBL] [Abstract][Full Text] [Related]
16. Cardiopulmonary bypass priming using a high dose of a balanced hydroxyethyl starch versus an albumin-based priming strategy.
Boldt J; Suttner S; Brosch C; Lehmann A; Röhm K; Mengistu A
Anesth Analg; 2009 Dec; 109(6):1752-62. PubMed ID: 19923501
[TBL] [Abstract][Full Text] [Related]
17. Intestinal elimination of hydroxyethyl starch?
Lenz K; Schimetta W; Pölz W; Kröll W; Gruy-Kapral C; Magometschnigg D
Intensive Care Med; 2000 Jun; 26(6):733-9. PubMed ID: 10945391
[TBL] [Abstract][Full Text] [Related]
18. A randomized, controlled, double-blind crossover study on the effects of 1-L infusions of 6% hydroxyethyl starch suspended in 0.9% saline (voluven) and a balanced solution (Plasma Volume Redibag) on blood volume, renal blood flow velocity, and renal cortical tissue perfusion in healthy volunteers.
Chowdhury AH; Cox EF; Francis ST; Lobo DN
Ann Surg; 2014 May; 259(5):881-7. PubMed ID: 24253140
[TBL] [Abstract][Full Text] [Related]
19. Hydroxyethyl starch (HES) does not directly affect renal function in patients with no prior renal impairment.
Dehne MG; Mühling J; Sablotzki A; Dehne K; Sucke N; Hempelmann G
J Clin Anesth; 2001 Mar; 13(2):103-11. PubMed ID: 11331169
[TBL] [Abstract][Full Text] [Related]
20. The effects of renal impairment on the pharmacokinetics and safety of fosfluconazole and fluconazole following a single intravenous bolus injection of fosfluconazole.
Sobue S; Tan K; Layton G; Leclerc V; Weil A
Br J Clin Pharmacol; 2004 Jun; 57(6):773-84. PubMed ID: 15151523
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
